Top Pharmaceuticals stocks in United States
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $767.39bn | 72.85 | 0.58% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $353.71bn | 15.76 | 3.24% |
MRKMerck & Co | $327.97bn | 56.36 | 2.32% |
ABBVAbbvie | $277.35bn | 31.03 | 3.81% |
AMGNAmgen | $164.06bn | 43.44 | 2.83% |
PFEPfizer | $163.65bn | 10.29 | 5.71% |
CELG RTBristol-Myers Squibb Co | $83.60bn | 0.01 | 4610.78% |
BMYBristol-Myers Squibb Co | $83.60bn | 11 | 5.6% |
GILDGilead Sciences | $81.83bn | 11.7 | 4.6% |
ZTSZoetis | $77.60bn | 32.46 | 0.92% |
MCKMcKesson | $72.89bn | 24.99 | 0.41% |
BIIBBiogen | $31.71bn | 23.55 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $23.48bn | 18.23 | 2.07% |
RPRXRoyalty Pharma | $15.91bn | 14.93 | 3.04% |
BMRNBiomarin Pharmaceutical | $14.34bn | 71.56 | n/a |
INCYIncyte | $12.87bn | 16.98 | n/a |
VTRSViatris | $12.39bn | 20.84 | 4.61% |
CTLTCatalent | $9.92bn | n/a | n/a |